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Editorial on the Research Topic
Applications of Metagenomics in Studying Human Cancer
Metagenomics is defined as analysis of DNA obtained directly from the environment (Hugenholtz
and Tyson, 2008) and is also referred to as environmental genomics, ecogenomics or community
genomics (Handelsman 2004). Recent studies have reported that microbial infection might be
responsible for about 16.1% of cancers (Banerjee et al., 2015). For example, Chronic infections with
hepatitis B virus (HBV) and hepatitis C virus (HCV) might be closely associated with cirrhosis, liver
cancers and Cholangiocarcinoma (Perz et al., 2006; Matsumoto et al., 2014), HCV infection
contributed much to the development of hepatocellular carcinoma (Saito et al., 1990), and a
large portion of human papilloma virus (HPV) infection played a crucial role in the development of
cervical carcinoma (An et al., 2003). More importantly, roles of the microbiota differ significantly
with types of cancers. Therefore, to explore metagenomics of cancers is helpful to shed light on the
underlying mechanisms of cancer as well as promote microbe-mediated cancer drug development.
With development of sequencing techniques, many methods have been developed for analyzing
metagenomics of cancers in the past decade, including experimental and computational methods
(Zhang et al., 2019; Fadiji and Babalola, 2020). However, there are still barriers to be solved in the
exploring metagenomics-related cancers (Laudadio et al., 2019). Both computational and
experimental methods on metagenomics are still in their early stages and more focus should be
put into this promising area. This Research Topic serves as a forum to discuss new methods of
analyzing metagenomics-related cancers.
Endometrial cancer (EC) is one of the most common female malignant tumors (Ryan et al., 2005;
Liu et al., 2019). The presence of poor prognostic factors driving tumor recurrence contributed much
to mortality of EC patients (Coll-De La Rubia et al., 2020). Zhang et al. employed the bioinformatics
tools to explore role of E2F family in EC. Zhang et al. found that expressions of E2F1, E2F2, E2F3,
E2F7, and E2F8 were significantly upregulated and the expressions of E2F4 were downregulated in
EC tissues. This finding implied clinical potential of E2F family in preventing and treating EC.
Cancer of unknown primary site (CUP) is a well-recognized and heterogeneous clinical disorder,
one of the 10 most common malignancies in developed countries, accounting for 3–5% of cancers in
both men and women and (Pavlidis and Pentheroudakis, 2010). Identifying tissue of origin is crucial
to early diagnose and treat CUP (Zhao et al., 2020). Zhang et al. developed an XGBoost-based
method for predicting cancer tissue-of-origin by using copy number variations. This method might
be potential for identifying the actual clinic pathological status of specific cancer.
Breast cancer (BC) is the most common female malignant tumor, which is of extremely high
morbidity andmortality (Wang et al., 2017). The cancer cells interact inevitably with the immune system
during the process of cancer development, which might inhibit or enhance tumor growth (Vinay et al.,
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2015). Understanding deeply immune evasion mechanism of BC is
critical to develop immunotherapies for breast cancer. Chen et al.
presented a multi-source data fusion scheme to investigate
regulatory mechanism of BC immune evasion.
Long non-coding RNA is a type of RNA with more than 200
nucleotides, which are not translated into proteins (Perkel 2013).
Accumulating evidences showed that lncRNAs were closely
associated with human cancers (Gutschner and Diederichs,
2012). The aberrance of lncRNA was involved in a large variety
of cancers (Gibb et al., 2011). Little was known about functional
roles of the lncRNAs in the cancers. Zhu et al. developed a decision
tree-based method for identifying cancer-related lncRNAs. Zhu
et al. also used the GO and the KEGG pathway to encode lncRNA,
and employed Minimum Redundancy Maximum Relevance
(mRMR) (Peng et al., 2005) to select discriminative GO and
KEGG terms. The selected GO and KEGG terms were helpful
to shed light on regulating mechanisms of lncRNAs in
tumorigenesis. The glioma is a type of brain tumor, accounting
for 30% of all brain tumors, and 80% of malignant brain tumours
(Goodenberger and Jenkins, 2012). Xu et al. explored the
prognostic value of MEG3 which is a maternally expressed and
imprinted long non-coding RNA gene, and investigated
correlations with immune infiltrates in Gliomas. Xu et al. found
that expressions of MEG3 were strongly related to the multiple
immune markers in gliomas, especially in low-grade glioma,
implying potential immunotherapeutic target for gliomas.
Clear cell renal cell carcinoma (ccRCC) is the most frequent
subtype of kidney cancer (Network 2013). Most of ccRCC are of
metastase which is main cause of mortality for ccRCC (Casuscelli
et al., 2019). Finding difference in expressed profiles of genes in
primary metastatic ccRCC is fundamental to understand
metastasis mechanism of ccRCC. Gao et al. identified a
metastasis-associated gene signature of ccRCC by
bioinformatics analysis on two gene expression profiles
(GSE105261 and GSE85258) which were downloaded from the
GEO (Gene Expression Omnibus) database (https://www.ncbi.
nlm.nih.gov/geo/). This might provide new insights into
therapeutic and early diagnostic biomarkers of ccRCC.
Hepatocellular Carcinoma (HCC) is the most common
primary liver cancer, with which over 80% patients occurred
in the developing countries (Yang and Roberts, 2010). Autophagy
is an evolutionarily conserved intracellular mechanism (Yazdani
et al., 2019), playing versatile roles in cellular process including
removal of unnecessary or dysfunctional components (Klionsky
2008) and recycling of cellular components (Mizushima and
Komatsu, 2011; Kobayashi 2015). It was reported that
autophagy played dual roles in the HCC. The autophagy can
inhibit but can promote development of HCC. HCC is of poor
prognosis. Wang et al. presented a multivariate Cox model for
exploring the influence of autophagy-related genes (AAGs) on
the prognosis of HCC. This model is potential to promote the
overall survival rate of HCC patients.
Alzheimer’s disease (AD) is a neurodegenerative disease and
its mechanism is poorly understood (Burns and Iliffe, 2009).
Single nucleotide polymorphism (SNP) refers to the substitution
of a single nucleotide at a specific position in the genome. SNP
was associated with many disease including AD. Zhou et al.
presented a multiple-step method for exploring association
between SNP and brain region of interest related to AD.
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